Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.
Law firms clash over Johnson & Johnson's talc settlement strategy. Beasley Allen accuses former partner of breaching agreement, while J&J prepares for third bankruptcy attempt to resolve cases.
Indian shares expected to open flat as markets await crucial U. S. inflation data. Global sentiment mixed with subdued Asian markets and positive Wall Street performance, while oil prices hit multi-year lows.
Apple's AirPods Pro 2 set to become FDA-approved hearing devices, potentially revolutionizing accessibility. This move could address barriers to hearing treatment and encourage earlier adoption among users.
A salmonella outbreak linked to a Wisconsin egg farm has affected 65 people across nine states. The farm has recalled all its eggs and suspended production as investigations continue.
Federal data shows a significant drop in youth e-cigarette use, with only 6% of students reporting use in 2024. Despite progress, concerns remain about middle school usage and emerging nicotine products.
Former President Donald Trump suggests backing marijuana decriminalization, emphasizing the need to avoid criminalizing personal possession and wasting taxpayer money on arrests.
Research shows 60% of US packaged baby food doesn't meet WHO nutritional guidelines. Issues include low protein, high sugar, and sodium content, raising concerns about children's health and dietary habits.
Kenvue, manufacturer of Tylenol, successfully defends against consumer lawsuit alleging deception in "Rapid Release" gelcaps marketing. Federal judge rules FDA regulations preempt state law claims.
Representatives press FDA to ban formaldehyde-containing hair products, citing cancer risks. Delayed action raises concerns about health impacts on Black women, who face hair discrimination.
Delaware's highest court will review an appeal by pharmaceutical companies to dismiss over 70,000 lawsuits linking Zantac to cancer. The case centers on the scientific validity of expert testimony.
Robert F. Kennedy Jr.'s endorsement of Donald Trump for the 2024 election sparks debate over its impact. Concerns arise about Kennedy's potential influence on a second Trump administration's staffing and policies.
The FDA rejected MDMA for PTSD treatment, dealing a blow to Rick Doblin's 30-year effort. Despite setbacks, Doblin remains committed to pursuing MDMA therapy globally and exploring new applications.
Indian shares set to rise following Fed Chair Powell's hint at rate cuts. GIFT Nifty indicates higher opening, with Asian markets and Wall Street responding positively to the news.
Walmart recalls nearly 10,000 cases of Great Value apple juice due to elevated inorganic arsenic levels. FDA upgrades recall urgency but states serious health risks unlikely.
A federal judge has temporarily halted New York's attorney general from enforcing against pregnancy centers promoting an unproven abortion reversal method, citing free speech concerns. The case highlights tensions between medical information and First Amendment rights.
Vice President Kamala Harris accepts Democratic presidential nomination. FDA approves updated coronavirus vaccines. Texas faces extreme heat and controversial transgender policy changes. Second-largest diamond discovered in Botswana.
A federal judge has dismissed remaining lawsuits against Kenvue and retailers over claims that Tylenol causes ADHD in children of pregnant users, citing insufficient scientific evidence and expert testimony.
New details emerge about Matthew Perry's ketamine addiction and the events leading to his untimely death. Five arrests shed light on the actor's struggle and the illegal supply chain involved.
The FDA has authorized the first at-home syphilis test, set to be available in September 2024. This development comes as syphilis cases surge to a 70-year high, with an 80% increase between 2018 and 2022.
WHO declares mpox a global emergency as cases surge. Bavarian Nordic's stock rise signals potential increased vaccine demand. New strain detected in Sweden raises mutation concerns.
British drugmaker GSK plans to dismiss a Zantac lawsuit in Florida after a court ruling excluded expert testimony linking the heartburn drug to prostate cancer. The case is part of ongoing litigation involving multiple pharmaceutical companies.
U. S. announces final prices for first-ever Medicare drug negotiation, affecting 10 costly medications. Merck's Januvia faces steepest cut at 79%, impacting 66 million beneficiaries.
The U. S. government anticipates $6 billion in savings from Medicare drug price negotiations in 2026. This initiative, part of the Inflation Reduction Act, aims to reduce healthcare costs for 66 million beneficiaries.
Republican VP nominee JD Vance supports Trump's monetary policy stance and criticizes Democratic rival Tim Walz's military record. Vance also addresses controversial past comments on family and voting policies.
A Delaware jury ruled that Ferring Pharmaceuticals infringed on fecal transplant patents owned by Finch Therapeutics and the University of Minnesota. The Swiss company must pay $25 million in damages and future royalties.
A U. S. appeals court has affirmed the dismissal of an animal rights group's lawsuit against the USDA over a Perdue Farms chicken label. The court ruled that the group lacked standing due to absence of future injury.
Lenmeldy, a groundbreaking $4. 25 million gene therapy for metachromatic leukodystrophy, raises questions about accessibility and affordability. The treatment's approval highlights challenges in diagnosing and treating rare genetic disorders.
Former President Trump suggests openness to limiting abortion pill availability through federal regulations, contradicting previous statements. This shift could impact his stance on reproductive rights issues.
U. S. agency holds Amazon responsible for dangerous third-party items, orders consumer notification. Amazon to contest decision. FDA issues separate warning on chemical peel products.
The FDA has approved Guardant Health's blood test for colorectal cancer screening. This approval could lead to Medicare coverage, potentially revolutionizing cancer detection methods.